Ioan-Facsinay, A., Kimpe, S.J. De, Hellwig, S.M.M., Lent, P.L., Hofhuis, F.M.A., Ojik, H.H. Van, ...
Sedlik, C., Sarraseca, J., Casal, I., Leclerc, C.
To develop a strategy that promotes efficient antiviral immunity, hybrid virus-like particles (VLP) were prepared by self-assembly of the modified porcine parvovirus VP2 capsid protein carrying a...
Sedlik, C., Dridi, A., Deriaud, E., Saron, M. F., Rueda, P., Sarraseca, J., ...
We previously demonstrated that chimeric porcine parvovirus-like particles (PPV:VLP) carrying heterologous epitopes, when injected intraperitoneally into mice without adjuvant, activate strong CD4+...
Sedlik, C., Dadaglio, G., Saron, M. F., Deriaud, E., Rojas, M., Casal, S. I., ...
Many approaches are currently being developed to deliver exogenous antigen into the major histocompatibility complex class I-restricted antigen pathway, leading to in vivo priming of CD8+ cytotoxic T...
Sedlik, C., Sarraseca, J., Casal, I., Leclerc, C.
To develop a strategy that promotes efficient antiviral immunity, hybrid virus-like particles (VLP) were prepared by self-assembly of the modified porcine parvovirus VP2 capsid protein carrying a...
Sedlik, C., Dridi, A., Deriaud, E., Saron, M. F., Rueda, P., Sarraseca, J., ...
We previously demonstrated that chimeric porcine parvovirus-like particles (PPV:VLP) carrying heterologous epitopes, when injected intraperitoneally into mice without adjuvant, activate strong CD4+...
Sedlik, C., Dadaglio, G., Saron, M. F., Deriaud, E., Rojas, M., Casal, S. I., ...
Many approaches are currently being developed to deliver exogenous antigen into the major histocompatibility complex class I-restricted antigen pathway, leading to in vivo priming of CD8+ cytotoxic T...